Canada:
Generic Damages In Life Sciences Patent Litigation: Strategic Considerations (Video Content)
18 February 2013
Gowling WLG
To print this article, all you need is to be registered or login on Mondaq.com.
In this presentation,
Christopher Van Barr and
Kiernan Murphy discuss strategic considerations relating to
generic damages in life sciences patent litigation.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from Canada
Articling Students' Mental Health
Lerners LLP
A 2022 study, released by a research team at the Université de Sherbrooke, provided the first comprehensive empirical study on wellness in the Canadian legal profession.